Selection of HLA-B57-associated Gag A146P mutant by HLA-B*48:01-restricted Gag140-147-specific CTLs in chronically HIV-1-infected Japanese

Microbes and Infection

Volumn 13, Issue 8-9, 2011, Pages 766-770

  Naruto, Takuya ^a   Murakoshi, Hayato ^a   Chikata, Takayuki ^a   Koyanagi, Madoka ^a   Kawashima, Yuka ^a   Gatanaga, Hiroyuki ^a,b   Oka, Shinichi ^a,b   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

CTL; Escape; HIV 1; HLA B*48:01; HLA B*57

Indexed keywords

EPITOPE; GAG PROTEIN; HLA B ANTIGEN; HLA B57 ANTIGEN;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPANESE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRAL GENETICS; VIRUS MUTATION;

COHORT STUDIES; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HLA-B ANTIGENS; HOST-PATHOGEN INTERACTIONS; HUMANS; JAPAN; MUTATION; PEPTIDES; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79959860726     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.03.009     Document Type: Article

References (11)

1. Kiepiela P., Leslie A.J., Honeyborne I., Ramduth D., Thobakgale C., Chetty S., Rathnavalu P., Moore C., Pfafferott K.J., Hilton L., Zimbwa P., Moore S., Allen T., Brander C., Addo M.M., Altfeld M., James I., Mallal S., Bunce M., Barber L.D., Szinger J., Day C., Klenerman P., Mullins J., Korber B., Coovadia H.M., Walker B.D., Goulder P.J. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004, 432:769-775.
2. Borghans J.A., Molgaard A., de Boer R.J., Kesmir C. HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24. PLoS One 2007, 2:e920.
3. Altfeld M., Kalife E.T., Qi Y., Streeck H., Lichterfeld M., Johnston M.N., Burgett N., Swartz M.E., Yang A., Alter G., Yu X.G., Meier A., Rockstroh J.K., Allen T.M., Jessen H., Rosenberg E.S., Carrington M., Walker B.D. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T Cell response against HIV-1. PLoS Med. 2006, 3:e403.
4. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., Bishop K., van der Stok M., Nair K., Khan N., Crawford H., Payne R., Leslie A., Prado J., Prendergast A., Frater J., McCarthy N., Brander C., Learn G.H., Nickle D., Rousseau C., Coovadia H., Mullins J.I., Heckerman D., Walker B.D., Goulder P. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 2007, 13:46-53.
5. Crawford H., Lumm W., Leslie A., Schaefer M., Boeras D., Prado J.G., Tang J., Farmer P., Ndung'u T., Lakhi S., Gilmour J., Goepfert P., Walker B.D., Kaslow R., Mulenga J., Allen S., Goulder P.J., Hunter E. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J. Exp. Med. 2009, 206:909-921.
6. Milicic A., Price D.A., Zimbwa P., Booth B.L., Brown H.L., Easterbrook P.J., Olsen K., Robinson N., Gileadi U., Sewell A.K., Cerundolo V., Phillips R.E. CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef. J. Immunol. 2005, 175:4618-4626.
7. Draenert R., Le Gall S., Pfafferott K.J., Leslie A.J., Chetty P., Brander C., Holmes E.C., Chang S.C., Feeney M.E., Addo M.M., Ruiz L., Ramduth D., Jeena P., Altfeld M., Thomas S., Tang Y., Verrill C.L., Dixon C., Prado J.G., Kiepiela P., Martinez-Picado J., Walker B.D., Goulder P.J. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 2004, 199:905-915.
8. Kawashima Y., Pfafferott K., Frater J., Matthews P., Payne R., Addo M., Gatanaga H., Fujiwara M., Hachiya A., Koizumi H., Kuse N., Oka S., Duda A., Prendergast A., Crawford H., Leslie A., Brumme Z., Brumme C., Allen T., Brander C., Kaslow R., Tang J., Hunter E., Allen S., Mulenga J., Branch S., Roach T., John M., Mallal S., Ogwu A., Shapiro R., Prado J.G., Fidler S., Weber J., Pybus O.G., Klenerman P., Ndung'u T., Phillips R., Heckerman D., Harrigan P.R., Walker B.D., Takiguchi M., Goulder P. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009, 458:641-645.
9. Martinez-Naves E., Barber L.D., Madrigal J.A., Vullo C.M., Clayberger C., Lyu S.C., Williams R.C., Gorodezky C., Markow T., Petzl-Erler M.L., Parham P. Interactions of HLA-B*4801 with peptide and CD8. Tissue Antigens 1997, 50:258-264.
10. Honeyborne I., Prendergast A., Pereyra F., Leslie A., Crawford H., Payne R., Reddy S., Bishop K., Moodley E., Nair K., van der Stok M., McCarthy N., Rousseau C.M., Addo M., Mullins J.I., Brander C., Kiepiela P., Walker B.D., Goulder P.J. Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J. Virol. 2007, 81:3667-3672.
11. Brumme Z.L., Tao I., Szeto S., Brumme C.J., Carlson J.M., Chan D., Kadie C., Frahm N., Brander C., Walker B., Heckerman D., Harrigan P.R. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS 2008, 22:1277-1286.